IBDEI0F3 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20264,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,20265,0)
 ;;=463.^^104^1168^22
 ;;^UTILITY(U,$J,358.3,20265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20265,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,20265,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,20265,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,20266,0)
 ;;=011.90^^104^1168^23
 ;;^UTILITY(U,$J,358.3,20266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20266,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,20266,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,20266,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,20267,0)
 ;;=465.9^^104^1168^24
 ;;^UTILITY(U,$J,358.3,20267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20267,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,20267,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,20267,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,20268,0)
 ;;=599.0^^104^1168^25
 ;;^UTILITY(U,$J,358.3,20268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20268,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,20268,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,20268,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,20269,0)
 ;;=616.10^^104^1168^26
 ;;^UTILITY(U,$J,358.3,20269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20269,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,20269,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,20269,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,20270,0)
 ;;=277.30^^104^1169^1
 ;;^UTILITY(U,$J,358.3,20270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20270,1,3,0)
 ;;=3^277.30
 ;;^UTILITY(U,$J,358.3,20270,1,4,0)
 ;;=4^AMYLOIDOSIS NOS
 ;;^UTILITY(U,$J,358.3,20270,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,20271,0)
 ;;=277.31^^104^1169^3
 ;;^UTILITY(U,$J,358.3,20271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20271,1,3,0)
 ;;=3^277.31
 ;;^UTILITY(U,$J,358.3,20271,1,4,0)
 ;;=4^FAM MEDITERRANEAN FEVER
 ;;^UTILITY(U,$J,358.3,20271,2)
 ;;=^189367
 ;;^UTILITY(U,$J,358.3,20272,0)
 ;;=277.39^^104^1169^2
 ;;^UTILITY(U,$J,358.3,20272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20272,1,3,0)
 ;;=3^277.39
 ;;^UTILITY(U,$J,358.3,20272,1,4,0)
 ;;=4^AMYLOIDOSIS,OTHER
 ;;^UTILITY(U,$J,358.3,20272,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,20273,0)
 ;;=446.21^^104^1169^4
 ;;^UTILITY(U,$J,358.3,20273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20273,1,3,0)
 ;;=3^446.21
 ;;^UTILITY(U,$J,358.3,20273,1,4,0)
 ;;=4^GOODPASTURE'S SYNDROME
 ;;^UTILITY(U,$J,358.3,20273,2)
 ;;=^52601^583.81
 ;;^UTILITY(U,$J,358.3,20274,0)
 ;;=580.0^^104^1169^8
 ;;^UTILITY(U,$J,358.3,20274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20274,1,3,0)
 ;;=3^580.0
 ;;^UTILITY(U,$J,358.3,20274,1,4,0)
 ;;=4^NEPHRITIS,AC PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,20274,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,20275,0)
 ;;=580.4^^104^1169^9
 ;;^UTILITY(U,$J,358.3,20275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20275,1,3,0)
 ;;=3^580.4
 ;;^UTILITY(U,$J,358.3,20275,1,4,0)
 ;;=4^NEPHRITIS,AC RAPIDLY PROGR
 ;;^UTILITY(U,$J,358.3,20275,2)
 ;;=^270339
 ;;^UTILITY(U,$J,358.3,20276,0)
 ;;=580.9^^104^1169^7
 ;;^UTILITY(U,$J,358.3,20276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20276,1,3,0)
 ;;=3^580.9
 ;;^UTILITY(U,$J,358.3,20276,1,4,0)
 ;;=4^NEPHRITIS,AC NOS
 ;;^UTILITY(U,$J,358.3,20276,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,20277,0)
 ;;=582.0^^104^1169^14
 ;;^UTILITY(U,$J,358.3,20277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20277,1,3,0)
 ;;=3^582.0
 ;;^UTILITY(U,$J,358.3,20277,1,4,0)
 ;;=4^NEPHRITIS,CHR PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,20277,2)
 ;;=^270347
 ;;^UTILITY(U,$J,358.3,20278,0)
 ;;=582.1^^104^1169^12
 ;;^UTILITY(U,$J,358.3,20278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20278,1,3,0)
 ;;=3^582.1
 ;;^UTILITY(U,$J,358.3,20278,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOUS
 ;;^UTILITY(U,$J,358.3,20278,2)
 ;;=^24388
 ;;^UTILITY(U,$J,358.3,20279,0)
 ;;=582.2^^104^1169^11
 ;;^UTILITY(U,$J,358.3,20279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20279,1,3,0)
 ;;=3^582.2
 ;;^UTILITY(U,$J,358.3,20279,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOPROLIF
 ;;^UTILITY(U,$J,358.3,20279,2)
 ;;=^24386
 ;;^UTILITY(U,$J,358.3,20280,0)
 ;;=582.4^^104^1169^15
 ;;^UTILITY(U,$J,358.3,20280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20280,1,3,0)
 ;;=3^582.4
 ;;^UTILITY(U,$J,358.3,20280,1,4,0)
 ;;=4^NEPHRITIS,CHR RAPID PROGR
 ;;^UTILITY(U,$J,358.3,20280,2)
 ;;=^270348
 ;;^UTILITY(U,$J,358.3,20281,0)
 ;;=582.81^^104^1169^10
 ;;^UTILITY(U,$J,358.3,20281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20281,1,3,0)
 ;;=3^582.81
 ;;^UTILITY(U,$J,358.3,20281,1,4,0)
 ;;=4^NEPHRITIS,CHR IN OTH DIS
 ;;^UTILITY(U,$J,358.3,20281,2)
 ;;=^270350
 ;;^UTILITY(U,$J,358.3,20282,0)
 ;;=582.9^^104^1169^13
 ;;^UTILITY(U,$J,358.3,20282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20282,1,3,0)
 ;;=3^582.9
 ;;^UTILITY(U,$J,358.3,20282,1,4,0)
 ;;=4^NEPHRITIS,CHR NOS
 ;;^UTILITY(U,$J,358.3,20282,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,20283,0)
 ;;=583.81^^104^1169^5
 ;;^UTILITY(U,$J,358.3,20283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20283,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,20283,1,4,0)
 ;;=4^NEPHRITIS IN OTH DIS
 ;;^UTILITY(U,$J,358.3,20283,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,20284,0)
 ;;=583.81^^104^1169^16
 ;;^UTILITY(U,$J,358.3,20284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20284,1,3,0)
 ;;=3^583.81
 ;;^UTILITY(U,$J,358.3,20284,1,4,0)
 ;;=4^SECONDARY GLOMERONEPHRITIS
 ;;^UTILITY(U,$J,358.3,20284,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,20285,0)
 ;;=583.9^^104^1169^6
 ;;^UTILITY(U,$J,358.3,20285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20285,1,3,0)
 ;;=3^583.9
 ;;^UTILITY(U,$J,358.3,20285,1,4,0)
 ;;=4^NEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,20285,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,20286,0)
 ;;=710.0^^104^1169^17
 ;;^UTILITY(U,$J,358.3,20286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20286,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,20286,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,20286,2)
 ;;=^72159^582.81
 ;;^UTILITY(U,$J,358.3,20287,0)
 ;;=582.89^^104^1170^2
 ;;^UTILITY(U,$J,358.3,20287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20287,1,3,0)
 ;;=3^582.89
 ;;^UTILITY(U,$J,358.3,20287,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,CHR
 ;;^UTILITY(U,$J,358.3,20287,2)
 ;;=^270349
 ;;^UTILITY(U,$J,358.3,20288,0)
 ;;=580.89^^104^1170^1
 ;;^UTILITY(U,$J,358.3,20288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20288,1,3,0)
 ;;=3^580.89
 ;;^UTILITY(U,$J,358.3,20288,1,4,0)
 ;;=4^NEPHRITIS INTERSTITIAL,AC
 ;;^UTILITY(U,$J,358.3,20288,2)
 ;;=^270340
 ;;^UTILITY(U,$J,358.3,20289,0)
 ;;=583.89^^104^1170^3
 ;;^UTILITY(U,$J,358.3,20289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20289,1,3,0)
 ;;=3^583.89
 ;;^UTILITY(U,$J,358.3,20289,1,4,0)
 ;;=4^NEPHROPATHY,ANALGESIC
 ;;^UTILITY(U,$J,358.3,20289,2)
 ;;=^83443
 ;;^UTILITY(U,$J,358.3,20290,0)
 ;;=042.^^104^1171^1
 ;;^UTILITY(U,$J,358.3,20290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20290,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,20290,1,4,0)
 ;;=4^AIDS
 ;;^UTILITY(U,$J,358.3,20290,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,20291,0)
 ;;=581.1^^104^1171^2
 ;;^UTILITY(U,$J,358.3,20291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20291,1,3,0)
 ;;=3^581.1
 ;;^UTILITY(U,$J,358.3,20291,1,4,0)
 ;;=4^NEPHRITIS EPIMEMBRANOUS (FSGS)
 ;;^UTILITY(U,$J,358.3,20291,2)
 ;;=^270344
 ;;^UTILITY(U,$J,358.3,20292,0)
 ;;=581.2^^104^1171^3
 ;;^UTILITY(U,$J,358.3,20292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20292,1,3,0)
 ;;=3^581.2
 ;;^UTILITY(U,$J,358.3,20292,1,4,0)
 ;;=4^NEPHROSIS MEMBRANOPROL
 ;;^UTILITY(U,$J,358.3,20292,2)
 ;;=^270345
 ;;^UTILITY(U,$J,358.3,20293,0)
 ;;=581.3^^104^1171^4
 ;;^UTILITY(U,$J,358.3,20293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20293,1,3,0)
 ;;=3^581.3
 ;;^UTILITY(U,$J,358.3,20293,1,4,0)
 ;;=4^NEPHROSIS,MINIMAL CHANGE
 ;;^UTILITY(U,$J,358.3,20293,2)
 ;;=^82320
 ;;^UTILITY(U,$J,358.3,20294,0)
 ;;=581.9^^104^1171^5
 ;;^UTILITY(U,$J,358.3,20294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20294,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,20294,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,20294,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,20295,0)
 ;;=446.0^^104^1171^6
 ;;^UTILITY(U,$J,358.3,20295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20295,1,3,0)
 ;;=3^446.0
 ;;^UTILITY(U,$J,358.3,20295,1,4,0)
 ;;=4^POLYARTERITIS
 ;;^UTILITY(U,$J,358.3,20295,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,20296,0)
 ;;=581.81^^104^1171^7
 ;;^UTILITY(U,$J,358.3,20296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20296,1,3,0)
 ;;=3^581.81
 ;;^UTILITY(U,$J,358.3,20296,1,4,0)
 ;;=4^SECONDARY NEPHROTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,20296,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,20297,0)
 ;;=710.0^^104^1171^8
 ;;^UTILITY(U,$J,358.3,20297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20297,1,3,0)
 ;;=3^710.0
 ;;^UTILITY(U,$J,358.3,20297,1,4,0)
 ;;=4^SYSTEMIC LUPUS
 ;;^UTILITY(U,$J,358.3,20297,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,20298,0)
 ;;=596.0^^104^1172^1
 ;;^UTILITY(U,$J,358.3,20298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20298,1,3,0)
 ;;=3^596.0
 ;;^UTILITY(U,$J,358.3,20298,1,4,0)
 ;;=4^BLADDER NECK OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,20298,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,20299,0)
 ;;=592.0^^104^1172^2
 ;;^UTILITY(U,$J,358.3,20299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20299,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,20299,1,4,0)
 ;;=4^CALCULUS OF KIDNEY
 ;;^UTILITY(U,$J,358.3,20299,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,20300,0)
 ;;=592.1^^104^1172^3
 ;;^UTILITY(U,$J,358.3,20300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20300,1,3,0)
 ;;=3^592.1
 ;;^UTILITY(U,$J,358.3,20300,1,4,0)
 ;;=4^CALCULUS OF URETER
 ;;^UTILITY(U,$J,358.3,20300,2)
 ;;=^124125
 ;;^UTILITY(U,$J,358.3,20301,0)
 ;;=591.^^104^1172^4
 ;;^UTILITY(U,$J,358.3,20301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20301,1,3,0)
 ;;=3^591.
 ;;^UTILITY(U,$J,358.3,20301,1,4,0)
 ;;=4^HYDRONEPHROSIS
 ;;^UTILITY(U,$J,358.3,20301,2)
 ;;=^59672
 ;;^UTILITY(U,$J,358.3,20302,0)
 ;;=344.61^^104^1172^5
 ;;^UTILITY(U,$J,358.3,20302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20302,1,3,0)
 ;;=3^344.61
